PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

Z. Z. Yang, D. M. Grote, S. C. Ziesmer, B. Xiu, Anne J Novak, Stephen Maxted Ansell

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

To determine the biological and clinical relevance of programmed death 1 (PD-1) in follicular lymphoma (FL), we characterized PD-1<sup>+</sup> T-cell subsets and assessed their biological function as well as potential clinical impact. We found that PD-1 is expressed on intratumoral CD4<sup>+</sup> T cells with both bright and dim intensity, representing two different sub-populations of cells. By immunohistochemistry, we found that CD4<sup>+</sup>PD-1<sup>high</sup> T cells predominantly reside in the lymph node follicles, while PD-1<sup>low</sup> T cells are mainly located in an interfollicular pattern. Intratumoral CD4<sup>+</sup>PD-1<sup>high</sup> T cells have a TFH cell phenotype, express CXCR5, secrete IL-21 and are BCL-6 positive with no TIM-3 expression. In contrast, CD4<sup>+</sup>PD-1<sup>low</sup> T cells have an exhausted phenotype, express TIM-3 and do not express BCL-6 and CXCR5. Functionally, CD4<sup>+</sup>PD-1<sup>high</sup> T cells actively supported B-cell growth, while CD4<sup>+</sup>PD-1<sup>low</sup> T cells displayed a reduced cytokine production and cell-signal transduction. Clinically, we observed that the numbers of CD4<sup>+</sup> or CD8<sup>+</sup> PD-1<sup>low</sup> T cells significantly correlate with a reduced overall survival in FL patients (P = 0.007 and 0.04 respectively; n = 32). In contrast, the number of CD4<sup>+</sup>PD-1<sup>high</sup> T cells was not associated with patient outcome. Taken together, these results indicated that PD-1 expression defines two sub-populations with distinct functions that differentially impact patient outcome in FL.

Original languageEnglish (US)
Article numbere281
JournalBlood Cancer Journal
Volume5
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Follicular Lymphoma
T-Lymphocytes
Survival
Population
Phenotype
T-Lymphocyte Subsets
Signal Transduction
B-Lymphocytes
Lymph Nodes
Immunohistochemistry
Cytokines

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. / Yang, Z. Z.; Grote, D. M.; Ziesmer, S. C.; Xiu, B.; Novak, Anne J; Ansell, Stephen Maxted.

In: Blood Cancer Journal, Vol. 5, No. 2, e281, 01.01.2015.

Research output: Contribution to journalArticle

@article{28c01de018fa47e59fb062f6611a60b2,
title = "PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival",
abstract = "To determine the biological and clinical relevance of programmed death 1 (PD-1) in follicular lymphoma (FL), we characterized PD-1+ T-cell subsets and assessed their biological function as well as potential clinical impact. We found that PD-1 is expressed on intratumoral CD4+ T cells with both bright and dim intensity, representing two different sub-populations of cells. By immunohistochemistry, we found that CD4+PD-1high T cells predominantly reside in the lymph node follicles, while PD-1low T cells are mainly located in an interfollicular pattern. Intratumoral CD4+PD-1high T cells have a TFH cell phenotype, express CXCR5, secrete IL-21 and are BCL-6 positive with no TIM-3 expression. In contrast, CD4+PD-1low T cells have an exhausted phenotype, express TIM-3 and do not express BCL-6 and CXCR5. Functionally, CD4+PD-1high T cells actively supported B-cell growth, while CD4+PD-1low T cells displayed a reduced cytokine production and cell-signal transduction. Clinically, we observed that the numbers of CD4+ or CD8+ PD-1low T cells significantly correlate with a reduced overall survival in FL patients (P = 0.007 and 0.04 respectively; n = 32). In contrast, the number of CD4+PD-1high T cells was not associated with patient outcome. Taken together, these results indicated that PD-1 expression defines two sub-populations with distinct functions that differentially impact patient outcome in FL.",
author = "Yang, {Z. Z.} and Grote, {D. M.} and Ziesmer, {S. C.} and B. Xiu and Novak, {Anne J} and Ansell, {Stephen Maxted}",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/bcj.2015.1",
language = "English (US)",
volume = "5",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

AU - Yang, Z. Z.

AU - Grote, D. M.

AU - Ziesmer, S. C.

AU - Xiu, B.

AU - Novak, Anne J

AU - Ansell, Stephen Maxted

PY - 2015/1/1

Y1 - 2015/1/1

N2 - To determine the biological and clinical relevance of programmed death 1 (PD-1) in follicular lymphoma (FL), we characterized PD-1+ T-cell subsets and assessed their biological function as well as potential clinical impact. We found that PD-1 is expressed on intratumoral CD4+ T cells with both bright and dim intensity, representing two different sub-populations of cells. By immunohistochemistry, we found that CD4+PD-1high T cells predominantly reside in the lymph node follicles, while PD-1low T cells are mainly located in an interfollicular pattern. Intratumoral CD4+PD-1high T cells have a TFH cell phenotype, express CXCR5, secrete IL-21 and are BCL-6 positive with no TIM-3 expression. In contrast, CD4+PD-1low T cells have an exhausted phenotype, express TIM-3 and do not express BCL-6 and CXCR5. Functionally, CD4+PD-1high T cells actively supported B-cell growth, while CD4+PD-1low T cells displayed a reduced cytokine production and cell-signal transduction. Clinically, we observed that the numbers of CD4+ or CD8+ PD-1low T cells significantly correlate with a reduced overall survival in FL patients (P = 0.007 and 0.04 respectively; n = 32). In contrast, the number of CD4+PD-1high T cells was not associated with patient outcome. Taken together, these results indicated that PD-1 expression defines two sub-populations with distinct functions that differentially impact patient outcome in FL.

AB - To determine the biological and clinical relevance of programmed death 1 (PD-1) in follicular lymphoma (FL), we characterized PD-1+ T-cell subsets and assessed their biological function as well as potential clinical impact. We found that PD-1 is expressed on intratumoral CD4+ T cells with both bright and dim intensity, representing two different sub-populations of cells. By immunohistochemistry, we found that CD4+PD-1high T cells predominantly reside in the lymph node follicles, while PD-1low T cells are mainly located in an interfollicular pattern. Intratumoral CD4+PD-1high T cells have a TFH cell phenotype, express CXCR5, secrete IL-21 and are BCL-6 positive with no TIM-3 expression. In contrast, CD4+PD-1low T cells have an exhausted phenotype, express TIM-3 and do not express BCL-6 and CXCR5. Functionally, CD4+PD-1high T cells actively supported B-cell growth, while CD4+PD-1low T cells displayed a reduced cytokine production and cell-signal transduction. Clinically, we observed that the numbers of CD4+ or CD8+ PD-1low T cells significantly correlate with a reduced overall survival in FL patients (P = 0.007 and 0.04 respectively; n = 32). In contrast, the number of CD4+PD-1high T cells was not associated with patient outcome. Taken together, these results indicated that PD-1 expression defines two sub-populations with distinct functions that differentially impact patient outcome in FL.

UR - http://www.scopus.com/inward/record.url?scp=84927924384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927924384&partnerID=8YFLogxK

U2 - 10.1038/bcj.2015.1

DO - 10.1038/bcj.2015.1

M3 - Article

C2 - 25700246

AN - SCOPUS:84927924384

VL - 5

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 2

M1 - e281

ER -